Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

Newsfile Corp

08 Jul 2026, 02:43 UTC · 1h ago

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL

What the story claims

3 claims · each scored for market impact

What matters in this story

1
GRAIL, Inc. is facing a securities class action lawsuit alleging it misled investors regarding the effectiveness and data of its NHS-Galleri trial. — Allegations of manipulating or concealing clinical trial data for a primary product are high-risk events that can damage company valuation and investor trust.
-0.60
2
The lawsuit claims the NHS-Galleri trial period was insufficient to demonstrate the achievability of a reduction in Stage III-IV cancers. — Failure to meet a primary clinical endpoint or the inability to prove efficacy is a fundamental negative for a biotech company's growth prospects.
-0.50
3
The lead plaintiff deadline for the GRAIL class action is August 4, 2026. — While a procedural milestone, the deadline indicates the litigation is advancing, maintaining a persistent overhang on the stock.
-0.10

Which stocks this story touches

6 related stories

PRNewsWire
3h ago
GRAIL, Inc. (GRAL) Securities Class Action Filed Following NHS-Galleri Trial Failure and $2.2 Billion Market Cap Loss -- HBSS
- class action
- healthcare
- lawsuit
Read

ROSEN, TOP-RANKED INVESTO… — GRAL -1.00 | NewsImpactScreener

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL

What matters in this story

GRAIL, Inc. (GRAL) Securities Class Action Filed Following NHS-Galleri Trial Failure and $2.2 Billion Market Cap Loss -- HBSS

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL

What matters in this story

GRAIL, Inc. (GRAL) Securities Class Action Filed Following NHS-Galleri Trial Failure and $2.2 Billion Market Cap Loss -- HBSS

How each ticker is affected

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally

Erasca (ERAS) Faces Securities Class Action After Stock Declines 48% on Drug Safety and IP Concerns-- HBSS

GeneDx Holdings (WGS) Hit with Securities Class Action Following 49% Stock Collapse -- HBSS

ROSEN, LEADING INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUBG

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL

What matters in this story

Next reads from the same story arc

GRAIL, Inc. (GRAL) Securities Class Action Filed Following NHS-Galleri Trial Failure and $2.2 Billion Market Cap Loss -- HBSS

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL

What matters in this story

Next reads from the same story arc

GRAIL, Inc. (GRAL) Securities Class Action Filed Following NHS-Galleri Trial Failure and $2.2 Billion Market Cap Loss -- HBSS

How each ticker is affected

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally

Erasca (ERAS) Faces Securities Class Action After Stock Declines 48% on Drug Safety and IP Concerns-- HBSS

GeneDx Holdings (WGS) Hit with Securities Class Action Following 49% Stock Collapse -- HBSS

ROSEN, LEADING INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUBG